A warm welcome to Oxford Cryotechnology, using computational methods for cryopreservation, and good luck to the founders!

Oxford Cryotechnology is the new company founded by our spokesperson, Dr Roman Bauer, together with Prof. Joao Pedro de Magalhaes (University of Birmingham) and Dr Emil Kendziorra (Tomorrow Biostasis), to bridge the gap between research and practice gold standards in cryopreservation of cells, tissues and organs.

The team behind Oxford Cryotech. From left to right: Dr Emil Kendziorra, Dr Roman Bauer, and Prof. Joao Pedro de Magalhaes.


Oxford Cryotechnology will take advantage of a wide range of computational methods and in-silico modelling strategies building on recent work that resulted in CryoDynaMo [1] (supported by EPSRC grant #EP/S001433/1), an extension of BioDynaMo that demonstrated the viability of agent-based modelling of cryopreservation protocols. 
The new company will be heavily invested in continuing R&I in the field (see also [2]), and this will open to new opportunities of iteratively improving CryoDynaMo against data from new experimental setups.
We at BioDynaMo are especially excited: Oxford Cryotechnology, by exploiting computational tools to accelerate progress in cryopreservation practice and research, will mark a change of pace in how BioDynaMo impacts the life science ecosystems… and not least because this activity can be expected to feed new growth opportunities and intuitions to the project.
We wish Dr Bauer and his collaborators all the best in this promising endeavour that could translate into impact in biomedicine at large, from transplant practices, all the way to interstellar travels!

Read more about Oxford Cryotechnology here.
 


References: 
  1. Jennings, J., Bojic, S., Sharpe, A. and Bauer, R., 2021. Simulating The Thermodynamic Processes of Cryopreservation Utilising The Cryodynamo Cryopreservation Modelling Package. Cryobiology, 103, p.171.
  2. Bojic, S., Murray, A., Bentley, B.L., Spindler, R., Pawlik, P., Cordeiro, J.L., Bauer, R. and De Magalhães, J.P., 2021. Winter is coming: the future of cryopreservation. BMC biology, 19(1), pp.1-20.

Comments

Post a Comment

Popular posts from this blog

Modelling lung cells to personalize radiotherapy (with BioDynaMo) among the Top 10 Breakthroughs of the Year in physics for 2024!

Image
 Last December the 12th Physics World has delighted announced its Top 10 Breakthroughs of the Year for 2024, which includes research in nuclear and medical physics, quantum computing, lasers, antimatter and (of course ^_^) BioDynaMo . The Top Ten is the shortlist for the Physics World Breakthrough of the Year, which will be revealed on Thursday 19 December. PhysicsWorld editorial team has looked back at all the scientific discoveries reported on since 1 January and has picked 10 they judge are the most important. In addition to being reported in Physics World in 2024, the breakthroughs must meet the following criteria:  Significant advance in knowledge or understanding Importance of work for scientific progress and/or development of real-world applications Of general interest to Physics World readers  You can listen to the editors making their case for the research in the Top10 in this podcast What do they say about the BioDynaMo research they selected: <<Modelling...
Read more

BioDynaMo in 2024 - End of the year remarks, and Holidays greetings

Image
Dear all,  as we are approaching the end of 2024, we would like to take a moment to reflect on our collaborative achievements within the BioDynaMo community. It has been a year marked by innovation, resilience, and shared commitment to advancing our understanding of various biological systems through innovative computational modelling. This year, the consortium had several important successes. We would like to specifically mention/highlight: The paper presenting BioDynaMo’s application to cancer treatment. Radiation-induced fibrosis is a major risk factor in radiotherapy for lung cancer patients. BioDynaMo members including our Nicolo as first author published in the very prestigious Nature Communications Medicine journal, showing how BioDynaMo can be used to simulate the impact of radiation on the lung on a single cell level. Such modelling can be used to improve radiotherapy: https://www.nature.com/articles/s43856-024-00442-w Also in the domain of oncology, a study leve...
Read more

Congratulations Lukas Breitwieser for successfully defending your PhD

Image
 On Monday, November 11, 2024, Lukas successfully defended his thesis work, “ Design and Analysis of an Extreme-Scale, High-Performance, and Modular Agent-Based Simulation Platform ” 👏 The core contributions of Lukas’s thesis work are: BioDynaMo significantly reduces the simulation runtime, enabling larger and more complex simulations, faster iterative development, and more extensive parameter exploration. Specifically, BioDynaMo can: simulate 500 billion agents (a 84x improvement over the state-of-the-art), scale to 84’096 CPU cores, significantly reduce the simulation time (e.g., BioDynaMo simulates an iteration of 800 million agents in 0.6 s instead of 5 s), and significantly increases the visualization performance by 39x.
Read more